Skip Nav

HIV/AIDS Clinical Trials

Recruiting Status Legend

Studies Seeking Participants

Recruiting
Not yet recruiting
Available for expanded access

Studies Not Seeking Participants

Active, not recruiting
Completed
Terminated
Suspended
Withdrawn
Enrolling by invitation
Temporarily not available for expanded access
No longer available for expanded access
Approved for marketing

Clinical Trial Search Results

4 studies were found about ( ibalizumab OR TMB-355 OR TNX-355 OR Hu5A8 )

TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1

Condition: HIV Infections

NCT ID: NCT00089700

Active, not recruiting

Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1

Condition: HIV

NCT ID: NCT00784147

Completed

Investigator-Sponsored Protocol - Continued Use of Ibalizumab

Condition: HIV Infections

NCT ID: NCT01056393

Active, not recruiting

Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers

Condition: Prevention of Infection With HIV-1

NCT ID: NCT01292174

Completed